We should not avoid diclofenac in the treatment of spondyloarthritis
- PMID: 30613611
- PMCID: PMC6291570
- DOI: 10.21037/atm.2018.09.42
We should not avoid diclofenac in the treatment of spondyloarthritis
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis.Ann Rheum Dis. 2018 Aug;77(8):1137-1142. doi: 10.1136/annrheumdis-2018-213089. Epub 2018 Apr 19. Ann Rheum Dis. 2018. PMID: 29674321 Free PMC article.
Similar articles
-
MI risk associated with naproxen and diclofenac in spondyloarthritis.Drug Ther Bull. 2019 Jan;57(1):5. doi: 10.1136/dtb.2018.000050. Drug Ther Bull. 2019. PMID: 30567848 No abstract available.
-
[MRI of axial spondyloarthritis: diagnostic role and pitfalls].Rev Med Suisse. 2016 Mar 9;12(509):495-6, 498-502. Rev Med Suisse. 2016. PMID: 27089638 French.
-
Formation of an artifact of diclofenac during acidic extraction of environmental water samples.J Chromatogr A. 2003 Sep 5;1011(1-2):221-6. doi: 10.1016/s0021-9673(03)01173-7. J Chromatogr A. 2003. PMID: 14518779
-
Structural Disease Progression in Axial Spondyloarthritis: Still a Cause for Concern?Curr Rheumatol Rep. 2017 Mar;19(3):14. doi: 10.1007/s11926-017-0639-7. Curr Rheumatol Rep. 2017. PMID: 28265849 Review.
-
[Drug therapy of ankylosing spondyloarthritis (Bechterew's disease)].Ter Arkh. 1978;50(12):116-25. Ter Arkh. 1978. PMID: 369020 Review. Russian. No abstract available.
References
Publication types
LinkOut - more resources
Full Text Sources